Every argument clarity score on this site is built from rows on this page. Each
question and answer was assessed with names hidden, the host's own answers included, on
four things from 1 to 5:
directness (does it answer the question asked), coherence (do the ideas follow),
precision (concrete details and clear references), compression (says a lot per word). The weighted
mix (30/30/25/15) is the exchange score. A person's published score averages their exchange
scores on raw tape only, at least 8 of them, shrunk toward the cohort mean.
Full method →
Answered raw tape
D 4 · C 4 · P 4 · Cm 4 4.00
Q Do you think India focused funds are much larger than they should be? Like for example, if Prashant were to only have a hundred million dollars to allocate to India, would you perform significantly better?
A I think if you're in the early stage component of the fund, fund seed to scale, Right. So you, we don't stop at supporting the company just for seed. And like Karthik was talking about this, being able to provide the entire continuum of, uh, support to the company, I think is something entrepreneurs value and they want you to be with them, uh, for a reasonable part of the early cycle, because, uh, it's not easy all, uh, I mean, see, there have been periods where we have had great funds who can follow on in series B and C in India, and there have been periods where there have not been, ah, where there's been a void in that market. So I think it's, if you want to support your companies and, and make sure that they have that capital continuity, I think it's good to have a certain scale.
AI assessment note: “make sure that they have that capital continuity, I think it's good to have a certain scale.”
Answered raw tape
D 4 · C 3 · P 3 · Cm 3 3.30
Q So where's the entrepreneurship opportunity here? For a 25 year old.
A I think, uh, to, to be able to use, I mean, so like I said, we don't want to build every aspect of the business, right? So, so let's say I'm a, uh, a trainer today, right? Uh, as a trainer, uh, or a, um, a nutritional coach, right? What am I basing some of my, uh, advisory or, uh, the, uh, Uh, interventions or the guidance I'm giving my, uh, I think, uh, they'll be able to, uh, function better with data. And I, I think that's what we feel these tools can empower that we can build. So I think every, every Coach who is providing, you know, some, uh, aspect of, uh, you know, intervention and support will be able to do better with Biopeak with data.
AI assessment note: “let's say I'm a trainer today... they'll be able to function better with data”
Not addressed raw tape
D 1 · C 3 · P 3 · Cm 3 2.40
Q How much does it cost you for the equipment?
A So first of all, uh, um, why do you go to ThyroCare? Because, uh, some doctor told you there is a, I mean, first of all, why did you go to a doctor? You went there because you think there is Some, some, some, something medically that's bothering you, right? And most doctors are specialists. So they specialize in a particular organ, a particular function of your body, right? And they, when they send you for a test, they actually send you for a test for that organ, for that functioning of that particular portion of your body, right? That's, we think medicine, one point or 2.2, and that's the old way of doing it. The medicine three point approach would be to take a more systemic whole body approach and, and look at, you know, whether it is your metabolism, whether it is your, um, how, how good is your cognitive function? How good is your Your physical and, uh, performance, uh, uh, at, at a muscular and at a range of motion level, right? So can you, can you look at things slightly more holistically and integrate them into a more informed view of your current State.
AI assessment note: “The medicine three point approach would be to take a more systemic whole body approach”
Redirected raw tape
D 1 · C 3 · P 2 · Cm 2 2.00
Q Hey, isn't NMN, okay, NMN capsules you get? Yeah.
A So, uh, you know, just to kind of, I mean, the membranes you were talking about, and you asked about this metabolites, right? So you can, uh, slightly more, of course, this is advanced lab work, and this is what we are trying to do at Biopeak. Can you measure the, some of those levels, which give you an indication? Is it, are you, where, where is the bottleneck? In, in that conversion process that he was talking about, you know, as you go through these, they call them complicated, multiple complexes. In your mitochondria, right? Yeah. As you go from complex one to two to three, uh, there are different reactions that kind of take you from one complex. If there is insufficiency in a particular thing that can take you from one complex to the other complex, you have a dysfunction, right? Can you measure that? And can you then target and see what do you fix, right? That's I think a more precise way of doing it. I think we're getting there.
AI assessment note: “this is advanced lab work, and this is what we are trying to do”
